[go: up one dir, main page]

CN114573446A - Method for preparing protocatechuic acid from phellinus igniarius medicinal material - Google Patents

Method for preparing protocatechuic acid from phellinus igniarius medicinal material Download PDF

Info

Publication number
CN114573446A
CN114573446A CN202011403414.0A CN202011403414A CN114573446A CN 114573446 A CN114573446 A CN 114573446A CN 202011403414 A CN202011403414 A CN 202011403414A CN 114573446 A CN114573446 A CN 114573446A
Authority
CN
China
Prior art keywords
protocatechuic acid
water
acid
filler
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011403414.0A
Other languages
Chinese (zh)
Other versions
CN114573446B (en
Inventor
丰加涛
梁鑫淼
钟正升
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN202011403414.0A priority Critical patent/CN114573446B/en
Publication of CN114573446A publication Critical patent/CN114573446A/en
Application granted granted Critical
Publication of CN114573446B publication Critical patent/CN114573446B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/10Process efficiency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a method for preparing protocatechuic acid from a phellinus igniarius medicinal material, which is characterized in that the phellinus igniarius medicinal material is extracted by pure water, a two-dimensional orthogonal liquid chromatography technology is adopted, pure water resistant C8YE silica gel filler is used as a separation material in one dimension for enrichment to obtain a protocatechuic acid crude product, and polar copolymerization C18HC bonded silica gel filler is used in two dimensions for preparation and purification to obtain the protocatechuic acid product with the purity of more than 95%. The preparation process has the advantages of stable process, high yield, high automation degree and easy operation, and can meet the requirement of large-scale production.

Description

一种从桑黄药材中制备原儿茶酸的方法A kind of method for preparing protocatechuic acid from Phellinus linteus

技术领域technical field

本方法涉及分离纯化技术领域,具体是一种从桑黄药材中制备原儿茶酸的方法。更进一步的,本发明是利用二维液相色谱技术从桑黄药材中制备高纯度原儿茶酸的方法,纯度可以达到95%以上。The method relates to the technical field of separation and purification, in particular to a method for preparing protocatechuic acid from Phellinus linteus. Furthermore, the present invention is a method for preparing high-purity protocatechuic acid from Phellinus linteus medicinal materials by using two-dimensional liquid chromatography technology, and the purity can reach more than 95%.

背景技术Background technique

桑黄是一种珍贵的多年生大型药用真菌,素有“森林黄金”之美称之美称,在《本草纲目》中有记载。属于担子菌门层菌纲非褶菌目多孔菌科针层孔菌属,在我国分布有四十个种。主要寄生在桑、柳、桦杨栎等树干上,其中以野生的桑树桑黄最为珍贵。Phellinus linteus is a precious perennial large medicinal fungus, known as "forest gold", which is recorded in "Compendium of Materia Medica". It belongs to the Basidiomycota Laminaria, Nonphyllum, Polyporaceae, and there are forty species distributed in my country. It is mainly parasitic on the trunks of mulberry, willow, birch poplar, etc. Among them, the wild mulberry Phellinus is the most precious.

桑黄作为我国传统真菌类中药,是目前国际公认的生物治癌领域中有效率排在第一位的药用菌。其包含多种结构类型的化学成分,包括多糖、黄酮、三萜类、芳香酸、氨基酸等;现代药理学实验也表明,桑黄具抗癌、免疫调节、抗肥胖、抗氧化和抗炎等多种药理学活性。Phellinus linteus, as a traditional fungal Chinese medicine in my country, is currently internationally recognized as the most efficient medicinal fungus in the field of biological cancer treatment. It contains chemical components of various structural types, including polysaccharides, flavonoids, triterpenoids, aromatic acids, amino acids, etc. Modern pharmacological experiments also show that Phellinus linteus has anti-cancer, immune regulation, anti-obesity, antioxidant and anti-inflammatory properties. Various pharmacological activities.

近年来,在天然化合物中寻找具有神经营养样作用且可增强神经营养因子作用的双靶标药物成为研究的热点。据研究表明原儿茶酸具有抗癌、抗氧化、抗炎症、降血糖等多种功效,是一种健康安全的有益小分子物质。In recent years, the search for dual-target drugs with neurotrophic-like effects and enhancing the effects of neurotrophic factors in natural compounds has become a research hotspot. According to research, protocatechuic acid has anti-cancer, antioxidant, anti-inflammatory, hypoglycemic and other effects, and is a healthy and safe beneficial small molecule substance.

原儿茶酸(3,4-二羟基苯甲酸),性状为白色粉末,结构式如下:Protocatechuic acid (3,4-dihydroxybenzoic acid), the property is white powder, the structural formula is as follows:

Figure BDA0002813149430000021
Figure BDA0002813149430000021

原儿茶酸分子式中具有多个-OH,与硅胶表面的硅醇基有一定的结合作用,这是导致该物质制备过程中拖尾严重、分离困难的主要原因,为了解决该问题,该专利所使用的一维和二维分离填料,分别采用多点温和键合、封尾技术和极性共聚等技术对填料表面进行处理,大大改善制备过程中的拖尾问题;There are multiple -OHs in the molecular formula of protocatechuic acid, which have a certain binding effect with the silanol groups on the surface of silica gel, which is the main reason for serious tailing and difficulty in separation during the preparation of this substance. In order to solve this problem, the patent The one-dimensional and two-dimensional separation fillers used are treated with multi-point mild bonding, tail-capping technology and polar copolymerization techniques respectively to treat the surface of the filler, which greatly improves the tailing problem in the preparation process;

原儿茶酸具有抗血小板凝集、降低心肌耗氧量、抑菌、镇痛等多方面药理活性,是一种重要的天然活性物质。近年来的研究发现了其具有抗氧化、抗癌及介导肿瘤细胞凋亡等许多新的药理作用;对缺血缺氧神经元具有一定的神经细胞保护作用;能显著的缓解白细胞介素1β对软骨细胞的炎症反应;能维持受损的软骨细胞的表型和促增殖作用;维持软骨细胞表型和促进细胞增殖等等。Protocatechuic acid has many pharmacological activities such as anti-platelet aggregation, reducing myocardial oxygen consumption, bacteriostasis and analgesia, and is an important natural active substance. In recent years, studies have found that it has many new pharmacological effects such as anti-oxidation, anti-cancer and mediating tumor cell apoptosis; it has a certain neuroprotective effect on ischemic and hypoxic neurons; it can significantly relieve interleukin-1β. Inflammatory response to chondrocytes; can maintain the phenotype and pro-proliferation of damaged chondrocytes; maintain chondrocyte phenotype and promote cell proliferation, etc.

原儿茶酸具有较强的抗氧化能力,对金黄色葡萄球菌、链球菌等具有明显抑制作用,并有收敛和促进伤面愈合的作用,可用于治疗炎症、发热和癌症等。Protocatechuic acid has strong antioxidant capacity, has obvious inhibitory effect on Staphylococcus aureus, Streptococcus, etc., and has the effect of astringent and promoting wound healing, and can be used to treat inflammation, fever and cancer.

从桑黄药材中提取制备原儿茶酸罕有报道,谱效关系不明确,因此制备该化合物对桑黄物质基础研究和药理活性研究具有重要意义;The extraction and preparation of protocatechuic acid from Phellinus linteus is rarely reported, and the spectrum-effect relationship is not clear. Therefore, the preparation of this compound is of great significance for the research on the material basis and pharmacological activity of Phellinus linteus.

鉴于以上技术背景及发展前景,提出本发明。In view of the above technical background and development prospects, the present invention is proposed.

发明内容SUMMARY OF THE INVENTION

本发明提供一种以桑黄药材为原料,采用二维液相色谱制备原儿茶酸的方法,操作步骤如下:The invention provides a method for preparing protocatechuic acid by taking Phellinus linteus as raw material and adopting two-dimensional liquid chromatography. The operation steps are as follows:

1.作为优选,利用桑黄药材采用纯水提取,料液比1:15~30,浸泡10~24小时,加热煮沸水提1~2小时,提取2~3次,合并得到水提液;1. As preferably, using Phellinus linteus medicinal materials to extract with pure water, the ratio of material to liquid is 1:15~30, soaking for 10~24 hours, heating and boiling water for 1~2 hours, extracting 2~3 times, and combining to obtain an aqueous extract;

2.作为优选,采用膜过滤技术对水提液进行中空纤维膜过滤,中空纤维膜滤芯精度10000~800000分子量,得到中空纤维膜透过液;2. As a preference, the water extract is filtered with a hollow fiber membrane using membrane filtration technology, and the accuracy of the hollow fiber membrane filter element is 10,000-800,000 molecular weight to obtain the permeate of the hollow fiber membrane;

3.作为优选,利用耐纯水C8YE硅胶填料,对原儿茶酸具有很好的富集作用,可以将中空纤维膜水相透过液进行大体积直接上样富集,填料为粒径30~60μm,孔径为

Figure BDA0002813149430000031
富集获得原儿茶酸粗品。3. As a preference, the use of pure water-resistant C8YE silica gel fillers has a good enrichment effect on protocatechuic acid, and the water phase permeate of the hollow fiber membrane can be directly loaded and enriched in large volumes. ~60μm, the pore size is
Figure BDA0002813149430000031
After enrichment, crude protocatechuic acid was obtained.

4.为了实现一维制备富集原儿茶酸粗品的目的,本发明采用了以下的技术方案:4. in order to realize the purpose of one-dimensional preparation and enrichment of protocatechuic acid crude product, the present invention adopts the following technical scheme:

一维液相色谱制备采用的洗脱条件为丙酮、乙腈、异丙醇(有机相)与酸水(水相)混合,水相为乙酸或磷酸中的一种或二种,比例为0.1~0.5%(v/v),按照有机相5~25%等度,5~25%线性梯度或台阶梯度,流速为0.1~0.2倍填料体积/min,温度25~45℃,载样量0.5~3.0%(样品溶液固体质量与填料质量之比),检测器为DAD紫外检测器,洗脱时间为20~60min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至20~80mg/mL为一维制备原儿茶酸粗品;The elution conditions used in the preparation of one-dimensional liquid chromatography are acetone, acetonitrile, isopropanol (organic phase) mixed with acid water (aqueous phase), and the aqueous phase is one or two of acetic acid or phosphoric acid, and the ratio is 0.1~ 0.5% (v/v), according to the organic phase 5-25% isocratic, 5-25% linear gradient or step gradient, the flow rate is 0.1-0.2 times the filler volume/min, the temperature is 25-45 ℃, the sample loading is 0.5- 3.0% (the ratio of the solid mass of the sample solution to the mass of the filler), the detector is a DAD UV detector, the elution time is 20-60 min, the fractions are collected according to the chromatographic peak curve of the detector, and all fractions are analyzed by liquid phase to confirm the original The tea acid fractions are combined and concentrated to 20-80 mg/mL to prepare crude protocatechuic acid in one dimension;

5.作为优选,二维制备采用极性共聚C18HC键合硅胶填料,填料粒径为10~40μm,孔径为

Figure BDA0002813149430000041
制备获得纯度>95%原儿茶酸;5. As a preference, the two-dimensional preparation adopts polar copolymerized C18HC bonded silica filler, the particle size of the filler is 10-40 μm, and the pore size is
Figure BDA0002813149430000041
Prepared to obtain >95% protocatechuic acid;

6.为了实现二维制备原儿茶酸的目的,本发明采用了以下的技术方案:6. in order to realize the purpose of two-dimensional preparation of protocatechuic acid, the present invention has adopted the following technical scheme:

二维液相色谱制备采用洗脱条件为丙酮、乙腈、异丙醇(有机相)与甲酸水(水相)混合,按照有机相5~25%等度,5~25%梯度或台阶等度,水相为甲酸比例为0.1~1.2%(v/v),流速为0.2~0.3倍填料体积/min,温度25~45℃,载样量0.2~2.0%(样品质量与填料质量之比),检测器为DAD紫外检测器,洗脱时间为30~80min,按照检测器色谱峰曲线对原儿茶酸的组分进行收集,所得馏分真空干燥,即可得到纯度>95%的原儿茶酸。Two-dimensional liquid chromatography preparation adopts the elution conditions of acetone, acetonitrile, isopropanol (organic phase) and formic acid water (aqueous phase) mixing, according to the organic phase 5-25% isocratic, 5-25% gradient or step isocratic , the water phase is formic acid, the ratio is 0.1-1.2% (v/v), the flow rate is 0.2-0.3 times the volume of filler/min, the temperature is 25-45°C, and the sample loading is 0.2-2.0% (the ratio of sample mass to filler mass) , the detector is DAD ultraviolet detector, the elution time is 30-80min, the components of protocatechuic acid are collected according to the chromatographic peak curve of the detector, and the obtained fractions are vacuum-dried to obtain protocatechu with purity>95% acid.

本发明具有如下优点:The present invention has the following advantages:

本发明与现有技术相比具有以下特点:Compared with the prior art, the present invention has the following characteristics:

1.桑黄化合物的一维分离填料采用耐纯水的合成工艺,可以对纯水相样品进行大体积上样,可以避免普通C18键合填料的键合相卷曲,失去保留的问题,二维分离填料采用极性共聚C18HC键合硅胶填料,对一维桑黄化合物原儿茶酸进行正交性分离,与一维分离填料具有互补性;1. The one-dimensional separation packing of Phellinus linteus uses a synthetic process that is resistant to pure water, which can be used for large-volume sample loading of pure water phase samples, which can avoid the curling of the bonded phase and the loss of retention of ordinary C18 bonded packing. The problem of two-dimensional The separation packing adopts polar copolymerized C18HC bonded silica gel packing, which can orthogonally separate the one-dimensional Phellinus compound protocatechuic acid, which is complementary to the one-dimensional separation packing;

2.原儿茶酸纯度高:由于本发明所用的技术方法,直接针对药材中所含的原儿茶酸进行制备,无需经过加热、酸碱的变化,原儿茶酸以在药材中本身存在的状态被制备出来,没有水解产物掺杂,因此得到的原儿茶酸纯度高,达到95%以上。2. The purity of protocatechuic acid is high: due to the technical method used in the present invention, the protocatechuic acid contained in the medicinal material is directly prepared without heating and changes in acid and alkali, and the protocatechuic acid exists in the medicinal material itself. It is prepared in the state of , without hydrolysis product doping, so the obtained protocatechuic acid has high purity, reaching more than 95%.

3.本发明所涉及的制备原儿茶酸的方法,仪器自动化程度高,操作简便,收率高,可以满足大规模生产的需求。3. The method for preparing protocatechuic acid involved in the present invention has the advantages of high degree of instrument automation, simple operation and high yield, and can meet the needs of large-scale production.

附图说明Description of drawings

图1是实施例1的原儿茶酸一维制备谱图;Fig. 1 is the one-dimensional preparation spectrogram of protocatechuic acid of embodiment 1;

图2是实施例1的原儿茶酸二维制备谱图;Fig. 2 is the protocatechuic acid two-dimensional preparation spectrogram of embodiment 1;

图3是实施例1的原儿茶酸液相分析谱图。FIG. 3 is a liquid phase analysis spectrum of protocatechuic acid in Example 1. FIG.

具体实施方式Detailed ways

现结合实例,对本发明做进一步说明。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变型,这些改进和变型也应视为本发明的保护范围。实例仅限于说明本发明,本发明不仅限于此。The present invention will now be further described with reference to examples. It should be pointed out that for those skilled in the art, without departing from the technical principle of the present invention, several improvements and modifications can also be made, and these improvements and modifications should also be regarded as the protection scope of the present invention. The examples are only intended to illustrate the invention and the invention is not limited thereto.

实施例1Example 1

称取桑黄药材100g,加入3L水溶液,浸泡24小时后加热煮沸水提8小时,收集水提液,固体物料再次按加入3L水溶液重复加水煮沸提收集水提液,重复提取1次,合并得到水提液,得到桑黄药材水提溶液,浓度为1.8mg/mL,中空纤维膜过滤(膜芯精度100000分子量)。Weigh 100g of Phellinus linteus medicinal materials, add 3L aqueous solution, soak for 24 hours, heat and boil for 8 hours, collect the water extract, add 3L aqueous solution to the solid material again, add water and boil again to collect the water extract, repeat the extraction once, and combine to obtain The aqueous extract is obtained to obtain an aqueous extract solution of Phellinus linteus with a concentration of 1.8 mg/mL, which is filtered by a hollow fiber membrane (membrane core precision is 100,000 molecular weight).

一维制备条件,色谱条件采用C8YE填料(制备柱规格:100×250mm,粒径30μm,孔径

Figure BDA0002813149430000051
质量1200g,华谱新创科技有限公司),流动相采用(A)乙腈(有机相)-(B)0.1%乙酸水(水相,v/v),梯度洗脱方式:纯水洗脱10min,乙腈(流动相A)体积浓度由10%经60min提高到20%乙腈(其余为流动相B)梯度洗脱60min,采用DAD紫外检测器选择254nm吸收波长,制备温度25℃,上样体积为3.3L/针,载样量0.5%(样品溶液固体质量与填料质量之比),流动相流速为300mL/min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至30mg/mL,得到一维制备原儿茶酸粗品,纯度36.51%,收率86.9%。One-dimensional preparation conditions, chromatographic conditions use C8YE packing (preparative column specifications: 100 × 250 mm, particle size 30 μm, pore size
Figure BDA0002813149430000051
Mass 1200g, Huapu Xinchuang Technology Co., Ltd.), mobile phase adopts (A) acetonitrile (organic phase)-(B) 0.1% acetic acid water (aqueous phase, v/v), gradient elution mode: pure water elution 10min , the volume concentration of acetonitrile (mobile phase A) was increased from 10% to 20% acetonitrile (the rest were mobile phase B) gradient elution for 60min over 60min, the DAD ultraviolet detector was used to select the absorption wavelength of 254nm, the preparation temperature was 25°C, and the sample volume was 3.3L/needle, the sample load is 0.5% (the ratio of the solid mass of the sample solution to the mass of the filler), the flow rate of the mobile phase is 300mL/min, the fractions are collected according to the detector chromatographic peak curve, and all fractions are analyzed by liquid phase to confirm the original The tea acid fractions were combined and concentrated to 30 mg/mL to obtain one-dimensionally prepared crude protocatechuic acid with a purity of 36.51% and a yield of 86.9%.

二维制备条件,色谱条件采用反相C18HC键合硅胶填料(制备柱规格:50×150mm,粒径10μm,孔径

Figure BDA0002813149430000061
质量300g,华谱新创科技有限公司),流动相选择(A)丙酮(有机相)-(B)含0.1%甲酸水(水相,质量浓度),采用体积浓度10%丙酮(流动相(A)等度洗脱(其余为流动相B),采用DAD紫外检测器选择320nm吸收波长,制备温度为25℃,进样量为20mL/针,流动相流速为60mL/min,按照检测器色谱峰曲线对原儿茶酸的馏分进行收集(按色谱峰收集),旋转蒸发至干,得到原儿茶酸化合物(产物经核磁和高分辨质谱结构解析,确定其为化合物原儿茶酸),经液相色谱分析,纯度为95.55%,收率93.2%。Two-dimensional preparation conditions, chromatographic conditions use reverse-phase C18HC bonded silica gel packing (preparative column size: 50 × 150 mm, particle size 10 μm, pore size
Figure BDA0002813149430000061
Mass 300g, Huapu Xinchuang Technology Co., Ltd.), mobile phase selection (A) acetone (organic phase)-(B) water containing 0.1% formic acid (aqueous phase, mass concentration), using volume concentration 10% acetone (mobile phase ( A) Isocratic elution (the rest are mobile phase B), use DAD ultraviolet detector to select 320nm absorption wavelength, preparation temperature is 25°C, injection volume is 20mL/needle, mobile phase flow rate is 60mL/min, according to the detector chromatography The peak curve is to collect the fractions of protocatechuic acid (collected according to the chromatographic peaks), and rotary evaporate to dryness to obtain the protocatechuic acid compound (the product is determined to be the compound protocatechuic acid by NMR and high-resolution mass spectrometry structural analysis), Through liquid chromatography analysis, the purity was 95.55%, and the yield was 93.2%.

实施例2Example 2

称取桑黄药材100g,溶于2L水溶液,浸泡30小时后加热煮沸水提6小时,收集水提液,固体物料再次按加入2L水溶液重复加水煮沸提收集水提液,重复提取2次,合并得到水提液,得到桑黄药材水提溶液,浓度为1.2mg/mL,中空纤维膜膜过滤,中空纤维膜膜芯精度500000分子量,透过液浓缩至40mg/mL。Weigh 100g of Phellinus linteus, dissolve in 2L aqueous solution, soak for 30 hours, heat and boil for 6 hours, collect the water extract, add 2L aqueous solution to the solid material again, add water and boil again to collect the water extract, repeat the extraction twice, and combine An aqueous extract is obtained to obtain an aqueous extraction solution of Phellinus linteus with a concentration of 1.2 mg/mL, filtered through a hollow fiber membrane, the core precision of the hollow fiber membrane is 500,000 molecular weight, and the permeate is concentrated to 40 mg/mL.

一维制备条件,色谱条件采用C8YE填料(制备柱规格:100×250mm,粒径60μm,孔径

Figure BDA0002813149430000073
质量1200g,华谱新创科技有限公司),流动相采用(A)乙腈(有机相)-(B)0.1%磷酸水(水相,v/v),台阶等度洗脱方式:纯水洗脱20min,乙腈(流动相A)体积浓度20%等度洗脱(其余为流动相B)60min,采用DAD紫外检测器选择254nm吸收波长,制备温度25℃,进样量为300mL/针,载样量0.75%(样品溶液固体质量与填料质量之比),流动相流速为300mL/min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至40mg/mL,得到一维制备原儿茶酸粗品,纯度46.82%,收率90.1%。One-dimensional preparation conditions, chromatographic conditions use C8YE packing (preparative column specifications: 100 × 250 mm, particle size 60 μm, pore size
Figure BDA0002813149430000073
Mass 1200g, Huapu Xinchuang Technology Co., Ltd.), mobile phase adopts (A) acetonitrile (organic phase)-(B) 0.1% phosphoric acid water (aqueous phase, v/v), step isocratic elution method: pure water washing Remove 20min, acetonitrile (mobile phase A) volume concentration 20% isocratic elution (the rest are mobile phase B) 60min, use DAD ultraviolet detector to select 254nm absorption wavelength, preparation temperature 25 ℃, injection volume is 300mL/needle, load The sample volume is 0.75% (the ratio of the solid mass of the sample solution to the mass of the filler), the flow rate of the mobile phase is 300 mL/min, and the fractions are collected according to the chromatographic peak curve of the detector. All fractions are analyzed by liquid phase to confirm the protocatechuic acid fraction. It was concentrated to 40 mg/mL to obtain one-dimensionally prepared crude protocatechuic acid with a purity of 46.82% and a yield of 90.1%.

二维制备条件,色谱条件采用反相C18HC键合硅胶填料(制备柱规格:50×150mm,粒径10μm,孔径

Figure BDA0002813149430000074
质量300g,华谱新创科技有限公司),流动相选择(A)丙酮(有机相)-(B)0.5%磷酸水(水相,质量浓度),采用5%丙酮(流动相A)60min提高至25%丙酮(其余为流动相B)梯度洗脱,采用DAD紫外检测器选择320nm吸收波长,制备温度为18℃,进样量为25mL/针,流动相流速为60mL/min,按照检测器色谱峰曲线对原儿茶酸的馏分进行收集(按色谱峰收集),旋转蒸发至干,得到原儿茶酸化合物(产物经核磁和高分辨质谱结构解析,确定其为化合物原儿茶酸),经液相色谱分析,纯度为96.68%,收率93.8%。Two-dimensional preparation conditions, chromatographic conditions using reversed-phase C18HC bonded silica gel packing (preparative column size: 50 × 150 mm, particle size 10 μm, pore size
Figure BDA0002813149430000074
Mass 300g, Huapu Xinchuang Technology Co., Ltd.), mobile phase selection (A) acetone (organic phase)-(B) 0.5% phosphoric acid water (aqueous phase, mass concentration), using 5% acetone (mobile phase A) 60min to improve To 25% acetone (the rest are mobile phase B) gradient elution, use DAD UV detector to select 320nm absorption wavelength, preparation temperature is 18 ℃, injection volume is 25mL/needle, mobile phase flow rate is 60mL/min, according to the detector Chromatographic peak curve The fractions of protocatechuic acid were collected (collected according to the chromatographic peaks), and rotary evaporated to dryness to obtain the protocatechuic acid compound (the product was determined to be the compound protocatechuic acid by NMR and high-resolution mass spectrometry structural analysis) , by liquid chromatography analysis, the purity is 96.68%, and the yield is 93.8%.

对比例1Comparative Example 1

与实施例1不同之处在于,以非基团修饰的硅胶(100~200目)为分离材料,其它条件同实施例1,无法富集得到原儿茶酸粗品,因此无法进行二维制备分离纯化,无法得到高纯原儿茶酸。The difference from Example 1 is that the non-group-modified silica gel (100-200 mesh) is used as the separation material, and other conditions are the same as those in Example 1, and the crude protocatechuic acid cannot be obtained by enrichment, so two-dimensional preparation and separation cannot be performed. After purification, high-purity protocatechuic acid could not be obtained.

对比例2Comparative Example 2

与实施例1不同之处在于,一维分离填料采用普通的十八烷基硅烷键合硅胶,其余制备条件相同,一维制备原儿茶酸粗品,液相分析纯度42.58%,收率44.9%。The difference from Example 1 is that the one-dimensional separation packing adopts ordinary octadecylsilane-bonded silica gel, and the other preparation conditions are the same, and the crude protocatechuic acid is one-dimensionally prepared. .

二维分离填料采用普通的十八烷基硅烷键合硅胶,其余制备条件相同,经液相色谱分析,原儿茶酸纯度为79.48%,收率73.8%。The two-dimensional separation packing adopts ordinary octadecylsilane-bonded silica gel, and the other preparation conditions are the same. According to the liquid chromatography analysis, the purity of protocatechuic acid is 79.48%, and the yield is 73.8%.

Claims (5)

1.一种从桑黄药材中制备原儿茶酸的方法,步骤如下:1. a method for preparing protocatechuic acid from Phellinus linteus, the steps are as follows: (1)将桑黄药材进行纯水煮沸提取,获得桑黄水提液;(1) carrying out pure water boiling extraction with Phellinus linteus medicinal material to obtain Phellinus linteus water extract; (2)将桑黄水提液进行中空纤维膜过滤,得到膜透过液;(2) carrying out hollow fiber membrane filtration with Phellinus linteus water extract to obtain membrane permeate; (3)利用耐纯水C8YE硅胶填料将膜透过液进行一维富集,获得原儿茶酸粗品,所用色谱填料为C8YE填料,洗脱条件为丙酮、乙腈、异丙醇中的一种或两种为有机相与酸水为水相作为流动相,水相为乙酸或磷酸中的一种或两种,比例为0.01~3.0%(v/v);按照有机相1~30%等度,1~30%线性梯度或台阶梯度,流速为0.01~1.0倍填料体积/min,温度15~55℃,载样量0.2~6.0%(样品溶液固体质量与填料质量之比),检测器为DAD紫外检测器,洗脱时间为40~300min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至10~300mg/mL为一维制备原儿茶酸粗品;(3) Use pure water-resistant C8YE silica gel filler to carry out one-dimensional enrichment of the membrane permeate to obtain crude protocatechuic acid. The chromatographic filler used is C8YE filler, and the elution conditions are one of acetone, acetonitrile, and isopropanol. Or both are organic phase and acid water is water phase as mobile phase, water phase is one or both of acetic acid or phosphoric acid, and the ratio is 0.01~3.0% (v/v); according to organic phase 1~30%, etc. degree, 1-30% linear gradient or step gradient, flow rate is 0.01-1.0 times the volume of filler/min, temperature is 15-55°C, sample loading is 0.2-6.0% (ratio of solid mass of sample solution to mass of filler), detector It is a DAD UV detector, the elution time is 40-300min, the fractions are collected according to the chromatographic peak curve of the detector, and all fractions are analyzed by liquid phase to confirm the protocatechuic acid fraction. Preparation of crude protocatechuic acid; (4)利用极性共聚C18HC键合硅胶填料将原儿茶酸粗品进行二维制备,得到高纯原儿茶酸产品,洗脱条件为洗脱条件为丙酮、乙腈、异丙醇中的一种或两种为有机相与酸水为水相作为流动相,水相为乙酸或磷酸中的一种或两种,比例为0.05~3.0%(v/v);按照有机相1~50%等度,1~50%线性梯度或台阶梯度,流速为0.02~1.2倍填料体积/min,温度15~55℃,载样量0.1~4%(样品溶液固体质量与填料质量之比),检测器为DAD紫外检测器,洗脱时间为15~200min,按照检测器色谱峰曲线对原儿茶酸的组分进行收集,所得馏分真空干燥,即可得到纯度>95%的原儿茶酸产品。(4) Two-dimensional preparation of crude protocatechuic acid by using polar copolymerized C18HC-bonded silica gel filler to obtain high-purity protocatechuic acid product, and the elution condition is that the elution condition is one of acetone, acetonitrile, and isopropanol or Two kinds are organic phase and acid water is water phase as mobile phase, and the water phase is one or both of acetic acid or phosphoric acid, and the ratio is 0.05~3.0% (v/v); according to the organic phase 1~50% isocratic , 1~50% linear gradient or step gradient, flow rate is 0.02~1.2 times of packing volume/min, temperature is 15~55 ℃, sample load is 0.1~4% (ratio of solid mass of sample solution to packing mass), the detector is DAD ultraviolet detector, the elution time is 15-200min, the components of protocatechuic acid are collected according to the chromatographic peak curve of the detector, and the obtained fractions are vacuum dried to obtain protocatechuic acid products with a purity of >95%. 2.根据权利要求1所述的方法,其特征在于,利用纯水对桑黄药材进行提取,料液比1:20~1:150(m/v),浸泡2~72小时;加热煮沸提取1~20小时,收集水提液,固体物料再次按料液比1:20~1:150(m/v)重复加水煮沸提取,收集水提液,共重复提取1~6次,合并得到水提液。2. The method according to claim 1, characterized in that, using pure water to extract Phellinus linteus medicinal materials, the ratio of material to liquid is 1:20~1:150 (m/v), soaking for 2~72 hours; heating and boiling for extraction For 1 to 20 hours, collect the water extract, and repeat the extraction of the solid material by adding water to boil again according to the material-to-liquid ratio of 1:20 to 1:150 (m/v). Extraction. 3.根据权利要求1所述的方法,其特征在于,采用膜过滤技术对水提液进行中空纤维膜过滤,中空纤维膜滤芯精度5000~1000000分子量,得到中空纤维膜水相透过液。3 . The method according to claim 1 , wherein the water extract is filtered with a hollow fiber membrane by using a membrane filtration technology, and the precision of the hollow fiber membrane filter element is 5,000-1,000,000 molecular weight to obtain the water-phase permeate of the hollow fiber membrane. 4 . 4.根据权利要求1所述的方法,其特征在于,一维制备采用耐纯水C8YE硅胶填料,对原儿茶酸具有很好的富集作用,可以将中空纤维膜水相透过液进行大体积直接上样富集,填料为粒径5~200μm,孔径为
Figure FDA0002813149420000021
富集获得原儿茶酸粗品。
4. The method according to claim 1, wherein the one-dimensional preparation adopts pure water-resistant C8YE silica gel filler, which has a very good enrichment effect on protocatechuic acid, and the hollow fiber membrane water phase permeate can be carried out. The large volume is directly loaded and enriched, the particle size of the filler is 5-200 μm, and the pore size is
Figure FDA0002813149420000021
After enrichment, crude protocatechuic acid was obtained.
5.根据权利要求1所述的方法,其特征在于,二维制备采用色谱填料为极性共聚键合技术的C18HC硅胶填料,可以对化合物原儿茶酸有很好的保留,同时与一维分离有很好的正交性,可以将小分子有机物等杂质进行分离去除,从而获得高纯化合物原儿茶酸,所用色谱填料为粒径5~200μm,孔径为
Figure FDA0002813149420000022
制备获得纯度>95%原儿茶酸产品。
5. The method according to claim 1, wherein the two-dimensional preparation adopts the C18HC silica gel filler of polar copolymerization bonding technology as the chromatographic filler, which can well retain the compound protocatechuic acid, and is compatible with the one-dimensional C18HC silica gel filler. The separation has good orthogonality, and impurities such as small molecular organics can be separated and removed to obtain a high-purity compound protocatechuic acid.
Figure FDA0002813149420000022
Prepared to obtain a protocatechuic acid product with a purity of >95%.
CN202011403414.0A 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material Active CN114573446B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011403414.0A CN114573446B (en) 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011403414.0A CN114573446B (en) 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material

Publications (2)

Publication Number Publication Date
CN114573446A true CN114573446A (en) 2022-06-03
CN114573446B CN114573446B (en) 2023-05-30

Family

ID=81768528

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011403414.0A Active CN114573446B (en) 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material

Country Status (1)

Country Link
CN (1) CN114573446B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002371032A (en) * 2001-06-15 2002-12-26 Morikawa Kenkoudou Kk 3,5-diprenyl-4-hydroxycinnamic acid for standard sample and method for producing the same
WO2010036520A1 (en) * 2008-09-26 2010-04-01 Wisconsin Alumni Research Foundation Mesoporous metal oxide materials for phosphoproteomics
CN103120706A (en) * 2012-10-23 2013-05-29 北京华润高科天然药物有限公司 Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology
CN104098465A (en) * 2014-06-18 2014-10-15 广西万寿堂药业有限公司 Technological method for extraction of protocatechuic acid from Blumea riparia (Bl.) DC
WO2016161138A1 (en) * 2015-03-31 2016-10-06 Stamets Paul Edward Antiviral activity from medicinal mushrooms and their active constituents
CN109908188A (en) * 2019-04-15 2019-06-21 吉林省蒲川生物医药有限公司 A kind of Phellinus anti-cancer effective component extract and its preparation method and purposes
CN111329905A (en) * 2018-12-18 2020-06-26 泰州医药城国科化物生物医药科技有限公司 Total alkaloid component extracted from coptis chinensis and refining method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002371032A (en) * 2001-06-15 2002-12-26 Morikawa Kenkoudou Kk 3,5-diprenyl-4-hydroxycinnamic acid for standard sample and method for producing the same
WO2010036520A1 (en) * 2008-09-26 2010-04-01 Wisconsin Alumni Research Foundation Mesoporous metal oxide materials for phosphoproteomics
CN103120706A (en) * 2012-10-23 2013-05-29 北京华润高科天然药物有限公司 Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology
CN104098465A (en) * 2014-06-18 2014-10-15 广西万寿堂药业有限公司 Technological method for extraction of protocatechuic acid from Blumea riparia (Bl.) DC
WO2016161138A1 (en) * 2015-03-31 2016-10-06 Stamets Paul Edward Antiviral activity from medicinal mushrooms and their active constituents
CN111329905A (en) * 2018-12-18 2020-06-26 泰州医药城国科化物生物医药科技有限公司 Total alkaloid component extracted from coptis chinensis and refining method thereof
CN109908188A (en) * 2019-04-15 2019-06-21 吉林省蒲川生物医药有限公司 A kind of Phellinus anti-cancer effective component extract and its preparation method and purposes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
秦春华等: "9种桑黄子实体中两种酚类活性成分的HPLC含量测定", 《湖北中医药大学学报》 *

Also Published As

Publication number Publication date
CN114573446B (en) 2023-05-30

Similar Documents

Publication Publication Date Title
US12043603B2 (en) Method for extracting and separating dihydromyricetin from rattan tea
CN105294623B (en) A sesquiterpene lactone compound, its preparation method and application
CN101050241A (en) Method for preparing MDG-1 polysaccharide of lilyturf root
CN102180938A (en) Method for preparing capilliposide
CN102526150A (en) Method for preparing total elecampane sesquiterpene lactone extract
CN104447910A (en) Method for preparation of loganin from traditional Chinese medicine Cornus officinalis
CN103893236B (en) Preparation method for concentrate of active substances in rape pollen
CN114573446B (en) Method for preparing protocatechuic acid from phellinus linteus medicinal material
CN101756965A (en) Application of maca imidazole alkaloid in preparation of cardiovascular drugs
CN115304651B (en) Method for extracting acteoside from paulownia leaves
CN107243005A (en) A kind of anti-cancer composition extracted from eupatorium lindleynun var. trifoliolatum and its preparation method and application
CN101618069B (en) Capsule preparation for treating bruise as well as bleeding and easing pain and preparation method and use thereof
CN102659740B (en) Method for extracting quercetin from eucommia leaves
CN112851604B (en) Compound D extracted from Cornus officinalis and having hypoglycemic effect, and preparation method and application thereof
CN111551656B (en) A kind of preparation method of high-purity corilagin
CN111170981B (en) Garcinia extract extracted from mangosteen, preparation method and application thereof
CN110240585B (en) Preparation method of agilawood tetraol
CN102389456A (en) Method for extracting isodon japonica var.galaucocalyx total diterpenoids or Glaucocalyxin A
CN105535050A (en) Radix angelica sinensis antitumor medicine
CN112851621A (en) Total iridoid extract of caulis et folium piperis, extraction and purification method and application thereof
CN108191933B (en) A kind of method for preparing new astilbin using tuckahoe as raw material
CN103524524B (en) Compound in a kind of shizandra berry and preparation and application thereof
CN114573539B (en) A method for preparing compound Phellibaumin D from Phellinus igniarius medicinal material
CN102675105A (en) Phenolic compound in tobacco as well as preparation method and application thereof
CN103739657A (en) Camellia saponin compound, preparation method, and application thereof, and anti-tumor drug prepared by using camellia saponin compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant